Literature DB >> 9300038

Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import.

A M Szilvay1, K A Brokstad, S O Bøe, G Haukenes, K H Kalland.   

Abstract

Oligomerization of Rev molecules has been shown to be required for Rev function. In addition to a Western blot assay monitoring dimer formation, a new in vivo assay analyzing formation of Rev heteromers in the cytoplasm and during nuclear import is presented here. The oligomerization assay is based upon the ability of Rev mutants with an intact nuclear localization signal (NLS) to interact specifically with mutants with a defective NLS and translocate such mutants to the nuclear compartments. Several of the mutants previously reported to be oligomerization defective were found to mediate nuclear and nucleolar localization of the NLS mutant. The Rev mutant previously named M4 was the only mutant tested that did not translocate the mutant with a defective NLS to the nucleus. Furthermore, the predominantly cytoplasmic localization of the M4 mutant suggests that oligomerization is important for effective nuclear import of Rev.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300038     DOI: 10.1006/viro.1997.8671

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.

Authors:  Dirk Daelemans; Elena Afonina; Jakob Nilsson; Gudrun Werner; Jorgen Kjems; Erik De Clercq; George N Pavlakis; Anne-Mieke Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-09       Impact factor: 11.205

2.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Baculovirus transregulator IE1 requires a dimeric nuclear localization element for nuclear import and promoter activation.

Authors:  Victoria A Olson; Justin A Wetter; Paul D Friesen
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Christoph Rader; Paul T Wingfield; David I Stuart; Alasdair C Steven; Jonathan M Grimes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 5.  Strategies to inhibit viral protein nuclear import: HIV-1 as a target.

Authors:  Aviad Levin; Abraham Loyter; Michael Bukrinsky
Journal:  Biochim Biophys Acta       Date:  2010-08-16

6.  Nuclear export and import of human hepatitis B virus capsid protein and particles.

Authors:  Hung-Cheng Li; Er-Yi Huang; Pei-Yi Su; Szu-Yao Wu; Ching-Chun Yang; Young-Sun Lin; Wen-Chang Chang; Chiaho Shih
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

7.  The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.

Authors:  Yoshiyuki Hakata; Masami Yamada; Naoto Mabuchi; Hisatoshi Shida
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1.

Authors:  Y Hakata; T Umemoto; S Matsushita; H Shida
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Dual roles for an arginine-rich motif in specific genome recognition and localization of viral coat protein to RNA replication sites in flock house virus-infected cells.

Authors:  P Arno Venter; Dawn Marshall; Anette Schneemann
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

10.  Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes.

Authors:  Stephen P Edgcomb; Angelique Aschrafi; Elizabeth Kompfner; James R Williamson; Larry Gerace; Mirko Hennig
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.